Trial record 1 of 1 for: C16011
Previous Study | Return to List | Next Study
Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
This study is currently recruiting participants.
Verified June 2017 by Takeda ( Millennium Pharmaceuticals, Inc. )
Millennium Pharmaceuticals, Inc.
Information provided by (Responsible Party):
Takeda ( Millennium Pharmaceuticals, Inc. )
First received: August 2, 2012
Last updated: June 8, 2017
Last verified: June 2017
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||September 1, 2018|
|Estimated Primary Completion Date:||September 1, 2018 (Final data collection date for primary outcome measure)|